Mood and Anxiety Disorders Treatment Development Program


This program supports studies of novel psychopharmacological and somatic approaches to alleviating the full range of symptoms associated with mood and anxiety disorders, including affective spectrum conditions, bipolar disorder, obsessive-compulsive disorder, post-traumatic stress disorders, and other psychiatric conditions. The program also supports studies that integrate investigations of the mechanism of treatment response with efficacy of treatments, and studies designed to develop biomarkers and other predictors of treatment response for these conditions.

Areas of Emphasis


Mi Hillefors, M.D., Ph.D.
Program Chief
6001 Executive Boulevard, Room 7125; MSC 9632